A. Covelli

P-Glycoprotein Inhibitor Valspodar (PSC 833) Increases the Intracellular Concentrations of Daunorubicin In Vivo in Patients With P-Glycoprotein–Positive Acute Myeloid Leukemia

Ulf Tidefelt, Jan Liliemark, Astrid Gruber et al. · Journal of Clinical Oncology · 2000 · 98 citations

Detection of clustered circulating tumour cells in early breast cancer

Ilona Krol, Fabienne D. Schwab, Roberta Carbone et al. · British Journal of Cancer · 2021 · 86 citations · Full text

Treatment of Poor Prognosis AML Patients Using PSC833 (Valspodar) Plus Mitoxantrone, Etoposide, and Cytarabine (PSC-MEC)

Ranjana H. Advani, Giuseppe Visani, D Milligan et al. · Advances in experimental medicine and biology · 1999 · 46 citations

Hematological Malignancy, Medicine, Prognosis +5

Modulation of multidrug resistance (MDR) in hematological malignancies

A. Covelli · Annals of Oncology · 1999 · 46 citations

Hematological Malignancy, Oncology, Medicine +5

Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.

Sergio Amadori, Adriana Ceci, A Comelli et al. · Journal of Clinical Oncology · 1987 · 45 citations

Hematological Malignancy, Oncology, Thirty-three Children +14